It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined 13% ...

Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years.

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...

Pfizer (PFE) closed the latest trading day at $25.23, indicating a -1.33% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.82%. Meanwhile, the Dow ...

On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.57 which represents a decrease of $-0.53 or -2.03% from the prior close of $26.1. The stock opened at $26.1 and touched a low of ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

组合疗法耐受性总体上与abemaciclib的已知安全性特征，以及vepdegestrant在其它临床试验中先前观察到的结果一致。最常见的任何级别治疗伴发不良事件 (TEAE)为腹泻、恶心和疲劳。没有观察到剂量限制毒性，也没有4级或5级的TEAE。

We recently published a list of 12 Best Affordable Stocks To Buy Right Now. In this article, we are going to take a look at ...

UnitedHealth Group has maintained its near term outlook, taking into account the Change Healthcare cyberattack impact.

根据ClinicalTrials官网，辉瑞正在开展一项1期临床研究，评估PF-07934040作为单一药物或与其他靶向药物联合用于KRAS基因突变晚期实体肿瘤患者的最佳剂量、疗效和安全性， 研究拟纳入非小细胞肺癌、结直肠癌、胰腺导管腺癌等患者，拟在国际范围内入组330名受试者。